|
The average number of patents issued yearly in the Providence metropolitan area is 535, earning the metro area the No. 43 spot on the Brookings Institute’s report analyzing patenting and innovation trends in the nation’s 358 largest metropolitan areas.
more
By PBN Staff
|
|
Forbes Magazine has named Swipley Inc. one of “America’s Most Promising Companies.” Swipely, which was founded in 2009, is the first Rhode Island company to make the list.
more
By PBN Staff
|
|
University of Massachusetts Dartmouth Professor John Buck has received a $743,000 research grant from the U.S. Office of Naval Research to help improve sensor arrays for sonar systems.
more
By PBN Staff
|
|
The Rhode Island Primary Care Physicians Corp., Rhode Island’s largest independent practice association, has formed an alliance with Rhode Island Behavioral Health Partners.
more
By PBN Staff
|
|
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration.
more
By Richard Asinof |
|
Rhode Island will be represented at two separate TED events, with Dennis Rebelo and Giovanni Feroce presenting at a TEDxPublic Street event and Rhode Island School of Design President John Maeda speaking at April’s TEDMED conference.
more
By PBN Staff
|
|
The Slater Technology Fund has committed to $250,000 in funding to a $750,000 seed round for Care Thread, a provider of secure mobile messaging and team-based collaboration solutions for the medical industry, Slater announced Tuesday.
more
By PBN Staff
|
|
Biomedical Structures LLC, a developer of biomedical textiles for medical devices, has expanded its medical textile development and manufacturing facilities and appointed a new vice president of research and development, the company announced Tuesday.
more
By PBN Staff
|
|
(Updated, 11:15 a.m.)
GreenBytes Inc., a developer of desktop virtualization solutions, has relocated its headquarters to downtown Providence and expanded its corporate offices.
more
By Emily Greenhalgh |
|
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences.
more
By Elizabeth Lopatto |